Home
Home REVIEW SLIDES VIDEOS FACULTY SPONSOR ABOUT TCTAP
EXHIBITION / SPONSORSHIP
2014 Sponsor
Exhibition Booth Floor Plan
TCTAP 2014 Final Program
2014 SPONSOR
CHONG KUN DANG
CKD Pharm. which was founded in 1941 with a motto "Better life through better medicine" has been developed one of Korean representative companies.
CKD newly launched novel anti-cancer drug "CAMTOBELL inj.(Belotecan)" in 2003
and will develop novel anti-diabetic drug(Lobeglitazone) in 2013.

368, 3 ga, Chungjeong-ro, Seodaemun-gu, Seoul
+82-2-3149-7936
http://www.ckdpharm.com


  Booth No. E023  

Exhibition Item
Duvie tab.(Lobeglitazone sulfate 0.5mg) is novel ppar-r agonist from korea.
Pregrel(clopidogrel resinate) is the IMD(Incrementally Modified Drug) which has relyable clinical outcome.
REVIEW
TCTAP Gallery
Daily Newspaper
Factoid		 SLIDES
Program: Slide Presentations
 VIDEOS
Wrap-up Interviews
Live Case Demonstrations
Special Events		 FACULTY
International Faculty
- Invited Faculty
- Faculty of the Year
Korean Faculty
- Invited Faculty
- Faculty of the Year		 SPONSOR
2014 Sponsor
Exhibition Booth Floor Plan		 ABOUT TCTAP
TCTAP
Board Members
Scientific TFT Team
CardioVascular Research Foundation(CVRF)
2nd Floor, Asan Institute for Education & Research, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea
Tel: 82-2-3010-7255/ Business registration number: 215-82-06387
Copyright ⓒ 2002 CVRF, Seoul, Korea. All rights reserved.